fda warning letters compounded semaglutide tirzepatide 2025 National Hispanic Medical Association | After GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and FDA Sends 30 Warning Letters

BBB complaint patterns are specific

For instance, patients using liraglutide (Saxenda), which is specifically approved for weight loss, typically experience average weight reductions of approximately 57% of their initial body weight after one year

But for many, eating less can feel miserable

Increasing your semaglutide concentration reactivates receptor sensitivity and restores appetite suppression, often producing renewed weight loss within 2 to 4 weeks

What youll learn Youll get a clear breakdown of how GLP-1 medications work, which ones are available, and practical insight into what to expect in terms of benefits and side effects